Diabetes Mellitus, Non-Insulin-Dependent
Showing 1 - 25 of >10,000
Diabetes, Non-Insulin-Dependent Trial (sulforaphane, Placebo)
Completed
- Diabetes Mellitus, Non-Insulin-Dependent
- sulforaphane
- Placebo
- (no location specified)
Jan 14, 2022
Diabetes, Type 2, Diabetes, Adult-Onset, Diabetes, Non-Insulin-Dependent Trial in Charleston (Technology Intensified)
Active, not recruiting
- Diabetes Mellitus, Type 2
- +4 more
- Technology Intensified
-
Charleston, South CarolinaMedical University of South Carolina
Apr 4, 2022
Diabetes, Diabete Type 2 Trial in Reno (Dayamed Arthur a novel intelligent medication adherence platform)
Completed
- Diabetes
- Diabete Type 2
- Dayamed Arthur a novel intelligent medication adherence platform
-
Reno, NevadaVA Sierra Nevada Health Care System
Mar 15, 2023
Diabetes, Type 2 Trial (Intermittently scanned continuous glucose monitor (isCGM), Education and individualized feedback)
Recruiting
- Diabetes Mellitus, Type 2
- Intermittently scanned continuous glucose monitor (isCGM)
- Education and coaching
-
Edmonton, Alberta, CanadaUniversity of Alberta Hospital / Kaye Edmonton Clinic
Oct 6, 2022
Weight Loss, Metabolic Syndrome, Diabetes, Type 2 Trial in Palo Alto (Continuous Glucose Monitor Device)
Recruiting
- Weight Loss
- +6 more
- Continuous Glucose Monitor Device
-
Palo Alto, CaliforniaSignos
May 24, 2023
Diabetes, Non Insulin Dependent Diabetes Trial in New York (Telehealth Bridge Visits, Standard of Care)
Not yet recruiting
- Diabetes Mellitus
- Non Insulin Dependent Diabetes Mellitus
- Telehealth Bridge Visits
- Standard of Care
-
New York, New YorkNYU Langone Health
Jun 2, 2023
Diabetes, Non-Insulin-Dependent, Hypertriglyceridemia Trial in Baton Rouge (Metformin Eicosapentaenoate, Metformin HCl and
Completed
- Diabetes Mellitus, Non-Insulin-Dependent
- Hypertriglyceridemia
- Metformin Eicosapentaenoate
- Metformin HCl and Vascepa
-
Baton Rouge, LouisianaPennington Biomedical Research Center
Apr 25, 2022
Type 2 Diabetes, Postprandial Hyperglycemia Trial in Stockholm (Insulin aspart (Novorapid®))
Completed
- Type 2 Diabetes Mellitus
- Postprandial Hyperglycemia
- Insulin aspart (Novorapid®)
-
Stockholm, SwedenDepartment of Medicine, Clinical pharmacology Unit, Karolinska U
May 24, 2022
Type 2 Diabetes, Nephropathy Trial (MK0954, losartan / Duration of Treatment: mean 3.4 years, Placebo / Duration of Treatment:
Completed
- Type 2 Diabetes
- Nephropathy
- MK0954, losartan / Duration of Treatment: mean 3.4 years
- Placebo / Duration of Treatment: mean 3.4 years
- (no location specified)
Feb 7, 2022
Diabetes, Type 2, Diabetes, Adult-Onset, Diabetes, Non-Insulin-Dependent Trial in Charleston (Diabetes Knowledge/Information,
Completed
- Diabetes Mellitus, Type 2
- +4 more
- Diabetes Knowledge/Information
- +3 more
-
Charleston, South CarolinaMedical University of South Carolina
Jun 16, 2021
Type 2 Diabetes Trial in Aurora (Acipimox, Placebo)
Completed
- Type 2 Diabetes
- Acipimox
- Placebo
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Nov 5, 2021
Diabetes, Type 2 Diabetes, Adult-Onset Diabetes Trial in Milwaukee (High Frequency Financial Incentive, Moderate Frequency
Completed
- Diabetes Mellitus
- +4 more
- High Frequency Financial Incentive
- +2 more
-
Milwaukee, WisconsinMedical College of Wisconsin
Oct 7, 2021
ERAS, Surgery, Non Insulin Dependent Diabetes Trial in Alexandria (ERAS protocol)
Recruiting
- ERAS
- +3 more
- ERAS protocol
-
Alexandria, EgyptFaculty of Medicine, Alexandria University
Sep 5, 2021
Diabetes, Non-Insulin-Dependent, Hypertensive Disease Trial in New Orleans (Liraglutide or Placebo)
Completed
- Diabetes Mellitus, Non-Insulin-Dependent
- Hypertensive Disease
- Liraglutide or Placebo
-
New Orleans, LouisianaTulane University Health Science Center, Tidewater building and
Jan 6, 2021
Diabetes Trial in Shanghai (Autologous regenerative islet transplantation for insulin-dependent diabetes mellitus)
Recruiting
- Diabetes
- Autologous regenerative islet transplantation for insulin-dependent diabetes mellitus
-
Shanghai, Shanghai, ChinaShanghai Changzheng Hospital
Mar 15, 2022
Hyperlipidemia, Diabetes, Type 2, Non-Insulin Dependent Diabetes Trial in Germany (Atorvastatin, Placebo)
Terminated
- Hyperlipidemia
- +2 more
- Atorvastatin
- Placebo
-
BAD Muenster AM Stein, Germany
- +13 more
Feb 17, 2021
Type 1 Diabetes, Type 2 Diabetes Treated With Insulin Trial in Seongnam (Intervention by medical staff based on a cloud system)
Completed
- Type 1 Diabetes Mellitus
- Intervention by medical staff based on a cloud system
-
Seongnam, Gyeonggi-do, Korea, Republic ofCHA Bundang Medical Center
Oct 22, 2022
Telemedicine, Insulin Dependent Diabetes 1 Trial in Aabenraa (Intervention group video consultations)
Recruiting
- Telemedicine
- Insulin Dependent Diabetes Mellitus 1
- Intervention group video consultations
-
Aabenraa, DenmarkSygehus Soenderjylland
Aug 30, 2022
Insulin Dependent Diabetes, Diabetes type2 Trial in Sirnak
Completed
- Insulin Dependent Diabetes
- Diabetes type2
-
Şirnak, Merkez, TurkeyŞirnak Devlet Hastanesi
Jun 22, 2023
Diabetes, Non-Insulin-Dependent, Erectile Dysfunction Trial in Amiens (DE assessment, AGE measurement)
Completed
- Diabetes Mellitus, Non-Insulin-Dependent
- Erectile Dysfunction
- DE assessment
- AGE measurement
-
Amiens, FranceCHU Amiens
Jul 17, 2020
Diabetes, Type 2, Insulin Dependent Diabetes Trial in Chicago (DM Discharge Toolkit)
Recruiting
- Diabetes Mellitus, Type 2
- Insulin Dependent Diabetes
- DM Discharge Toolkit
-
Chicago, IllinoisNorthwestern Memorial Hospital
Jan 31, 2023
Type 2 Diabetes, NAFLD Trial (Drinking powder supplement)
Not yet recruiting
- Type 2 Diabetes
- NAFLD
- Drinking powder supplement
- (no location specified)
Dec 8, 2022
Type 1 Diabetes Trial in Trondheim (Glucagon)
Recruiting
- Type 1 Diabetes
-
Trondheim, NorwayDepartment of Endocrinology, St. Olavs Hospital
Jul 17, 2023
Type 2 Diabetes, Multiple Dose Insulin Therapy Trial (Personalized treatment)
Not yet recruiting
- Type 2 Diabetes Mellitus
- Multiple Dose Insulin Therapy
- Personalized treatment
- (no location specified)
Nov 18, 2023
Diabetes, Type 2, Insulin Resistance, Diabetes Trial in Cairo (High intensity interval training, moderate intensity aerobic
Recruiting
- Diabetes Mellitus, Type 2
- Insulin Resistance, Diabetes
- High intensity interval training
- moderate intensity aerobic exercise
-
Cairo, Egypt
- +3 more
Jun 3, 2023